High-dose therapy followed by autologous hematopoietic stem cell(HSC)transplant is considered standard of care for eligible patients with multiple myeloma.The o
The new kidney allocation scheme(KAS)in effect since December 4th 2014 was designed to overcome the shortcomings of previous system.A key feature of the new KAS
Solid organ transplantation is limited by suitable donor organ availability and the geographic limitations that lead to prolonged ischemic times.Ex vivo organ p
Allo-antibodies,particularly when donor specific,are one of the most important factors that cause both early and late graft dysfunction.The authors review the c